SCHEMBL6016436

SCHEMBL6016436

CCOC(=O)CCCc1ccc(Nc2ncc(F)c(Nc3cccc(O)c3)n2)cc1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SYK P43405 17/20 0.70
AURKA O14965 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6016453 1.00 SYK (0.70) SYKAURKA
SCHEMBL18594624 0.94 SYK (0.71) SYKAURKA
SCHEMBL6016632 0.83 SYK (0.64) SYKAURKA
SCHEMBL6016675 0.83 SYK (0.64) SYKAURKA
SCHEMBL8999965 0.83 SYK (1.00) SYKAURKA
SCHEMBL656379 0.82 SYK (0.70) SYKAURKA
SCHEMBL656845 0.82 SYK (0.70) SYKAURKA
SCHEMBL6016537 0.81 SYK (0.63) SYK
SCHEMBL6016262 0.81 SYK (0.63) SYK
SCHEMBL657982 0.81 SYK (0.71) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471915-A4 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS INC (US) 2006-02-15 EP disclosed
EP-1471915-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Rigel Pharmaceuticals, Inc. (US) 2004-11-03 EP disclosed
WO-2003063794-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS, INC. (US) 2003-08-07 WO disclosed